Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 279Triple Negative Breast Neoplasms 146Neoplasm Metastasis 27Ovarian Neoplasms 23Carcinoma, Non-Small-Cell Lung 17Inflammatory Breast Neoplasms 15Pancreatic Neoplasms 12Neoplasms 11Endometrial Neoplasms 11Breast Neoplasms, Male 11Colorectal Neoplasms 8Carcinoma, Ductal, Breast 8Stomach Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 7Lung Neoplasms 7Prostatic Neoplasms 6Melanoma 6Fallopian Tube Neoplasms 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Pathologic Complete Response 5HER2-positive Breast Cancer 5Carcinoma, Ovarian Epithelial 5Esophageal Neoplasms 4Carcinoma, Lobular 4Urinary Bladder Neoplasms 3Small Cell Lung Carcinoma 3Recurrence 3Multiple Myeloma 3

Interventions

Melatonin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Cancer - Female × Carboplatin × Breast × Clear all
NCT07103447 2025-08-05

Prospective Multicenter Single-arm Trial: AK112 + Nab-paclitaxel/Carboplatin Neoadjuvant for TNBC

West China Hospital

Phase 2 Not yet recruiting
54 enrolled
Breast

Breast Cancer - Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡